Parameters | Total number of patients No. % | HER-2 overexpression | P53 immunoexpression | ||
---|---|---|---|---|---|
 |  | Positive No. % | Negative No. % | Positive No. % | Negative No. % |
Type of breast tissue | Â | Â | Â | Â | Â |
Normal | 20 (17.39) | 0 (0) | 20 (100) | 0 (0) | 20 (100) |
Benign (fibroadenoma) | 25 (21.74) | 0 (0) | 25 (100) | 0 (0) | 25 (100) |
Malignant | 70 (60.87) | 33 (47.14) | 37 (52.86) | 25 (35.71) | 45 (64.29) |
 | P < 0.05 |  |  | P < 0.05 |  |
Histological type | Â | Â | Â | Â | Â |
Lobular carcinomas | 8 (11.43) | 1 (12.50) | 7 (87.50) | 2 (25) | 6 (75) |
Ductal carcinomas including: | 62 (88.57) | 32 (51.61) | 30 (48.39) | 23 (37.10) | 39 (62.90) |
 | P < 0.05 |  |  | P > 0.05 |  |
Pure IDC | 47 (67.14) | 19 (40.43) | 28 (59.57) | 18 (38.30) | 29 (61.70) |
IDC + DCIS | 9 (12.86) | 7 (77.68) | 2 (22.22) | 2 (22.22) | 7 (77.78) |
IDC+ Paget's | 2 (2.86) | 2 (100) | 0 (0) | 1 (50) | 1 (50) |
DCIS + Paget's | 1 (1.44) | 1 (100) | 0 (0) | 1 (100) | 0 (0) |
Pure DCIS | 3 (4.29) | 3 (100) | 0 (0) | 1 (33.33) | 2 (66.67) |
 | P < 0.05 |  |  | P > 0.05 |  |
Tumor grade | Â | Â | Â | Â | Â |
Well-moderately differentiated (I and II) | 14 (20) | 7 (50) | 7 (50) | 2 (14.29) | 12 (85.71) |
Poorly differentiated (III) | 56 (80) | 26 (46.43) | 30 (53.57) | 23 (41.07) | 33 (58.93) |
 | P > 0.05, R > 0.3 |  |  | P > 0.05, | R > 0.3 |
Tumor size | Â | Â | Â | Â | Â |
Tis | 4 (5.71) | 4 (100) | 0 (0) | 2 (50) | 2 (50) |
T1 (≤ 2 cm) | 7 (10) | 2 (28.57) | 5 (71.43) | 2 (28.57) | 5 (71.43) |
T2 (2 > -5 cm) | 38 (54.29) | 13 (34.21) | 25 (65.79) | 6 (15.79) | 32 (84.21) |
T3 (> 5 cm) | 19 (27.14) | 13 (68.42) | 6 (31.58) | 14 (73.68) | 5 (26.32) |
T4 (anyT+other) | 2 (2.86) | 1 (50) | 1 (50) | 1 (50) | 1 (50) |
 | P < 0.05 | R < 0.3 |  | P < 0.05 | R > 0.3 |
Axillary lymph nodes1 | Â | Â | Â | Â | Â |
Negative | 27 (48.21) | 6 (22.22) | 2 (77.78) | 7 (25.93) | 20 (74.07) |
Positive | 29 (51.79) | 19 (65.52) | 10 (34.48) | 17 (58.62) | 12 (41.38) |
 | P < 0.05 |  |  | P < 0.05 |  |
Age of the patient | Â | Â | Â | Â | Â |
< 35 years | 19 (27.14) | 12 (63.16) | 7 (36.84) | 8 (42.11) | 11 (57.89) |
> 35years | 51 (72.86) | 21 (41.18) | 30 (58.82) | 17 (33.33) | 34 (66.67) |
 | P > 0.05 |  |  | P > 0.05 |  |
Tumor recurrence | Â | Â | Â | Â | Â |
Primary | 51 (72.86) | 17 (33.33) | 34 (66.67) | 13 (25.49) | 38 (74.51) |
Recurrent | 19 (27.14) | 16 (84.21) | 3 (15.79) | 12 (63.16) | 7 (36.84) |
 | P < 0.05 |  |  | P < 0.05 |  |